NEW CATHETER BASED DEVICES AND PROCEDURES DRIVING HEMOSTASIS VALVE INNOVATION
The viability of new interventions depend on more robust componentry
Today’s hemostasis valves are a vexingly difficult engineering challenge. Beyond the minimum requirements per ISO11070 and ISO10555 for pressure and vacuum decay, emergent invasive catheter therapies are demanding much more from the introducer componentry, especially the hemostasis valve. In this article, we review some of the factors rendering older valves inadequate, and some things to consider when choosing a device development partner.